Progyny (NASDAQ: PGNY) reported Q3 EPS of $0.40, $0.26 better than the analyst estimate of $0.14. Revenue for the quarter came in at $286.62 million versus the consensus estimate of $296.85 million.

GUIDANCE:

Progyny sees FY2024 EPS of $1.54-$1.57, versus the consensus of $1.57. Progyny sees FY2024 revenue of $1.135-1.15 billion, versus the consensus of $1.173 billion.

For earnings history and earnings-related data on Progyny (PGNY) click here.